Expertise in
2
conditions

Vincent S. Khoo

Fulham Road, 
London, ENG, GB 
Expertise in
2
conditions
Fulham Road, 
London, ENG, GB 

Overview

Vincent Khoo practices practicing medicine in London, United Kingdom.

Mr. Khoo is highly rated in 2 conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Lymphofollicular Hyperplasia, Bladder Cancer, Prostatectomy, and Orchiectomy.

He is actively involved in clinical research, co-authoring 202 peer reviewed articles and participating in 7 clinical trials.

Gender

Male

Locations

Fulham Road, London, ENG, United Kingdom

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

Randomised Phase 3 Trial of Enzalutamide in Androgen Deprivation Therapy With Radiation Therapy for High Risk, Clinically Localised, Prostate Cancer: ENZARAD
Randomised Phase 3 Trial of Enzalutamide in Androgen Deprivation Therapy With Radiation Therapy for High Risk, Clinically Localised, Prostate Cancer: ENZARAD
Enrollment Status: Active_not_recruiting
Publish Date: May 06, 2026
Intervention Type: Drug, Radiation
Study Drugs: Enzalutamide, Conventional NSAA, LHRHA
Study Phase: Phase 3
DASL-HiCaP: Darolutamide Augments Standard Therapy for Localised Very High-Risk Cancer of the Prostate (ANZUP1801): A Randomised Phase 3 Double-blind, Placebo-controlled Trial of Adding Darolutamide to Androgen Deprivation Therapy and Definitive or Salvage Radiation in Very High Risk, Clinically Localised Prostate Cancer
DASL-HiCaP: Darolutamide Augments Standard Therapy for Localised Very High-Risk Cancer of the Prostate (ANZUP1801): A Randomised Phase 3 Double-blind, Placebo-controlled Trial of Adding Darolutamide to Androgen Deprivation Therapy and Definitive or Salvage Radiation in Very High Risk, Clinically Localised Prostate Cancer
Enrollment Status: Active_not_recruiting
Publish Date: May 06, 2026
Intervention Type: Radiation, Drug
Study Drugs: Darolutamide, Luteinizing Hormone-Releasing Hormone Analog
Study Phase: Phase 3
Imperial Prostate 4: Comparative Health Research Outcomes of NOvel Surgery in Prostate Cancer
Imperial Prostate 4: Comparative Health Research Outcomes of NOvel Surgery in Prostate Cancer
Enrollment Status: Completed
Publish Date: March 24, 2025
Intervention Type: Procedure
Study Phase: Not Applicable
Local Cytoreductive Treatments for Men With Newly Diagnosed Metastatic Prostate Cancer in Addition to Standard of Care Treatment
Local Cytoreductive Treatments for Men With Newly Diagnosed Metastatic Prostate Cancer in Addition to Standard of Care Treatment
Enrollment Status: Active_not_recruiting
Publish Date: February 07, 2025
Intervention Type: Procedure, Combination product
Study Drug: Standard of Care
Study Phase: Phase 2
Randomised Phase 3 Trial of Enzalutamide in First Line Androgen Deprivation Therapy for Metastatic Prostate Cancer: ENZAMET
Randomised Phase 3 Trial of Enzalutamide in First Line Androgen Deprivation Therapy for Metastatic Prostate Cancer: ENZAMET
Enrollment Status: Active_not_recruiting
Publish Date: February 06, 2025
Intervention Type: Drug
Study Drugs: Enzalutamide, Non-Steroidal Anti Androgen, Luteinizing Hormone Releasing Hormone Analog or Surgical Castration
Study Phase: Phase 3
A Randomised Phase II Trial of Adaptive Image Guided Standard or Dose Escalated Tumour Boost Radiotherapy in the Treatment of Transitional Cell Carcinoma of the Bladder
A Randomised Phase II Trial of Adaptive Image Guided Standard or Dose Escalated Tumour Boost Radiotherapy in the Treatment of Transitional Cell Carcinoma of the Bladder
Enrollment Status: Active_not_recruiting
Publish Date: June 09, 2020
Intervention Type: Radiation
Study Phase: Phase 2
A Randomised Trial of Conventional Care Versus Radioablation (Stereotactic Body Radiotherapy) for Extracranial Oligometastases
A Randomised Trial of Conventional Care Versus Radioablation (Stereotactic Body Radiotherapy) for Extracranial Oligometastases
Enrollment Status: Unknown
Publish Date: August 21, 2019
Intervention Type: Radiation, Other
Study Phase: Phase 2/Phase 3
View 6 Less Clinical Trials

200 Total Publications

Targeted Prostate Cancer Screening in Carriers of BRCA1 or BRCA2 Pathogenic Germline Variants Detects Clinically Relevant Disease: 5-year Results from the IMPACT Study.
Targeted Prostate Cancer Screening in Carriers of BRCA1 or BRCA2 Pathogenic Germline Variants Detects Clinically Relevant Disease: 5-year Results from the IMPACT Study.
Journal: European urology
Published: October 23, 2025

Frequently Asked Questions about Vincent S. Khoo

Is Vincent S. Khoo a top-rated expert for Prostate Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Vincent S. Khoo is classified as an Distinguished expert for Prostate Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Vincent S. Khoo participate in research or clinical trials?

Yes. Vincent S. Khoo has published 200 articles and abstracts on conditions like Prostate Cancer. You can view a list of Vincent S. Khoo's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Khoo's expertise for a condition
ConditionClose
    View All 14 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile